IJGC conversations

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Christianne Lok and Michael Seckl to discuss 2025 GTD Guidelines. 

Michael Seckl is a Professor of Molecular Oncology at Imperial College London, where he leads research in lung cancer and trophoblastic disease. He earned his medical degree from UCL, completed oncology training, and obtained a PhD in signal transduction from the University of London. He directs the National Trophoblastic Disease and MOGCT Centre. An international leader in trophoblastic disease, he has held key roles in ISSTD, EOTTD, and EURACAN, and serves on multiple editorial and grant committees. His work is widely funded and recognized, earning him a Fellowship of the Academy of Medical Sciences (FMedSci) in 2017.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Núria Agustí and David Viveros-Carreño to discuss Radiation alone vs Chemoradiation in Intermediate Risk Cervical Cancer. Dr. Agustí specializes in gynecologic oncology at Hospital Clinic of Barcelona. She is currently a PhD researcher at the University of Barcelona and engaged in a postdoctoral fellowship at MD Anderson Cancer Center, USA. She recently completed the IJGC Editorial Fellowship program. Dr. Viveros-Carreño is a Gynecologic Oncologist at Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo (CTIC), and Clínica Universitaria Colombia in Bogotá, Colombia. 

In this episode of the IJGC conversations 2025 June Editor's Choice, Editorial Fellow Louisa Proppe, Sofia Bigardi and Rosanu Nelia Marina discusses the contents of the 2025 June issue of IJGC. 

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds to discuss ctDNA in Endometrial Cancer .

Dr. Capasso completed her OBGYN residency at Fondazione Policlinico Agostino Gemelli (Rome, Italy), where she worked in the Gynecologic Oncology Unit with a focus on clinical and translational research in endometrial cancer. From May 2022 to May 2023, she was a Visiting Research Fellow at Mayo Clinic (Rochester, MN, USA), leading projects on AI, the microbiome, and ctDNA in endometrial cancer. She is currently a consultant in the Gynecologic Oncology Unit at Gemelli and continues to collaborate with Mayo Clinic as a research collaborator.

Camilla Nero, MD, PhD, is a clinician-scientist in the Division of Gynecologic Oncology at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, where her translational work focuses on gynecological cancers. She has authored key studies on dual CDK12/13 inhibition in patient-derived ovarian cancer organoids and numerous reviews on treatment resistance and novel therapeutic strategies. In 2024, she was awarded the AIRC Next Gen Clinician Scientist Grant to support her independent research in gynecological cancers at Gemelli.

Evelyn A. Reynolds, M.D., is a board-certified Gynecologic Oncologist specializing in surgical care for women with gynecologic cancers. She has hed faculty positions at the University of Kansas and Morehouse School of Medicine. Since returning to Mayo Clinic in 2023, she has also expanded her academic role, focusing her research on the early detection of endometrial cancer, optimizing surgical outcomes and reducing healthcare disparities.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Hani Marcus to discuss the IDEAL Framework. Mr. Marcus is a Consultant Neurosurgeon at the National Hospital for Neurology and Neurosurgery and Honorary Associate Professor at the UCL Queen Square Institute of Neurology.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Koji Matsuo to discuss Modified Radical Hysterectomy for Stage IB1 Cervical Cancer.

Dr. Matsuo is a professor in the area of gynecologic oncology. Equally attentive to patient care, he devotes his work to scholarly activity related to patient outcomes, quality improvement, and healthcare service research in gynecologic malignancies.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Félix Boria to discuss the Risk Factor for Unsuccessful SLN Mapping.

Dr. Boria is an attending physician of the gynecologic oncology division at the Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain. He completed his PhD at the Universidad Autónoma de Madrid, where his research focused on PET/CT in advanced ovarian cancer.

In this episode of the IJGC conversations 2025 May Editor's Choice, Editorial Fellow Christian Braun, Julia Gelissen and Kyra Fischer discusses the contents of the 2025 May issue of IJGC. 

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Jolyn Taylor to discuss SUGAR Initiative: Glycemic control in the perioperative period. 

Dr. Taylor is an Associate Professor of Gynecologic Oncology at MD Anderson Cancer Center. She serves as the Associate Chief Quality and Value Officer and the Patient Safety Quality Officer for the Division of Surgery and focuses her research on ways to improve the quality of patient care.